Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion
Condition(s):Pulmonary TuberculosisLast Updated:March 12, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Pulmonary TuberculosisLast Updated:March 12, 2019Completed
Condition(s):Pulmonary TuberculosisLast Updated:February 1, 2018Completed
Condition(s):TuberculosisLast Updated:June 18, 2023Completed
Condition(s):TuberculosisLast Updated:February 27, 2023Completed
Condition(s):TuberculosisLast Updated:May 1, 2018Completed
Condition(s):HealthyLast Updated:March 18, 2024Recruiting
Condition(s):TuberculosisLast Updated:December 24, 2018Unknown status
Condition(s):Tuberculosis, PulmonaryLast Updated:February 22, 2024Active, not recruiting
Condition(s):Tuberculosis InfectionLast Updated:April 10, 2018Withdrawn
Condition(s):TuberculosisLast Updated:April 18, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.